These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16722643

  • 1. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y, Yoshida J, Kodera Y, Katoh A, Takada J, Sakurai H.
    J Med Chem; 2006 Jun 01; 49(11):3251-6. PubMed ID: 16722643
    [Abstract] [Full Text] [Related]

  • 2. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH, Liboiron BD, Sun Y, Bellman KD, Setyawati IA, Patrick BO, Karunaratne V, Rawji G, Wheeler J, Sutton K, Bhanot S, Cassidy C, McNeill JH, Yuen VG, Orvig C.
    J Biol Inorg Chem; 2003 Jan 01; 8(1-2):66-74. PubMed ID: 12459900
    [Abstract] [Full Text] [Related]

  • 3. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.
    J Inorg Biochem; 2006 Feb 01; 100(2):260-9. PubMed ID: 16387366
    [Abstract] [Full Text] [Related]

  • 4. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
    Thompson KH, Chiles J, Yuen VG, Tse J, McNeill JH, Orvig C.
    J Inorg Biochem; 2004 May 01; 98(5):683-90. PubMed ID: 15134913
    [Abstract] [Full Text] [Related]

  • 5. The pharmacology of the insulinomimetic effect of zinc complexes.
    Sakurai H, Adachi Y.
    Biometals; 2005 Aug 01; 18(4):319-23. PubMed ID: 16158223
    [Abstract] [Full Text] [Related]

  • 6. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
    Kordowiak AM, Dabroś W, Kajda B.
    Horm Metab Res; 2002 Oct 01; 34(10):556-60. PubMed ID: 12439783
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
    Katoh A, Matsumura Y, Yoshikawa Y, Yasui H, Sakurai H.
    J Inorg Biochem; 2009 Apr 01; 103(4):567-74. PubMed ID: 19162327
    [Abstract] [Full Text] [Related]

  • 8. In vivo insulin-mimetic activity of [N,N'-1,3-propyl-bis(salicyladimine)]oxovanadium(IV).
    Xie M, Xu G, Li L, Liu W, Niu Y, Yan S.
    Eur J Med Chem; 2007 Jun 01; 42(6):817-22. PubMed ID: 17343957
    [Abstract] [Full Text] [Related]

  • 9. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P, Vieites M, Torre MH, Costa-Filho AJ, Cerecetto H, González M, Lavaggi ML, Adachi Y, Sakurai H, Gambino D.
    J Inorg Biochem; 2006 Feb 01; 100(2):281-7. PubMed ID: 16386797
    [Abstract] [Full Text] [Related]

  • 10. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y.
    Biochem Biophys Res Commun; 2001 Mar 01; 281(5):1190-3. PubMed ID: 11243860
    [Abstract] [Full Text] [Related]

  • 11. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
    Li YR, Gao LH, Ma YL, Niu YF, Liu WP, Li L.
    Yao Xue Xue Bao; 2008 Mar 01; 43(3):318-22. PubMed ID: 18630272
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.
    Wei YB, Yang XD.
    Biometals; 2012 Dec 01; 25(6):1261-8. PubMed ID: 23015214
    [Abstract] [Full Text] [Related]

  • 13. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
    Yoshikawa Y, Ueda E, Kawabe K, Miyake H, Takino T, Sakurai H, Kojima Y.
    J Biol Inorg Chem; 2002 Jan 01; 7(1-2):68-73. PubMed ID: 11862542
    [Abstract] [Full Text] [Related]

  • 14. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M, Gao L, Li L, Liu W, Yan S.
    J Inorg Biochem; 2005 Feb 01; 99(2):546-51. PubMed ID: 15621288
    [Abstract] [Full Text] [Related]

  • 15. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H, Fujii K, Watanabe H, Tamura H.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1095-101. PubMed ID: 7575515
    [Abstract] [Full Text] [Related]

  • 16. Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex.
    Adachi Y, Yoshikawa Y, Yoshida J, Kodera Y, Katoh A, Takada J, Sakurai H.
    Biochem Biophys Res Commun; 2006 Jul 07; 345(3):945-50. PubMed ID: 16707105
    [Abstract] [Full Text] [Related]

  • 17. Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships.
    Rangel M, Amorim MJ, Nunes A, Leite A, Pereira E, de Castro B, Sousa C, Yoshikawa Y, Sakurai H.
    J Inorg Biochem; 2009 Apr 07; 103(4):496-502. PubMed ID: 19195710
    [Abstract] [Full Text] [Related]

  • 18. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
    Adachi Y, Yoshida J, Kodera Y, Kato A, Yoshikawa Y, Kojima Y, Sakurai H.
    J Biol Inorg Chem; 2004 Oct 07; 9(7):885-93. PubMed ID: 15378407
    [Abstract] [Full Text] [Related]

  • 19. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
    Passadouro M, Metelo AM, Melão AS, Pedro JR, Faneca H, Carvalho E, Castro MM.
    J Inorg Biochem; 2010 Sep 07; 104(9):987-92. PubMed ID: 20627316
    [Abstract] [Full Text] [Related]

  • 20. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y, Liu W, Tian C, Xie M, Gao L, Chen Z, Chen X, Li L.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):213-9. PubMed ID: 17651728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.